CIBC World Market’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.8M | Sell |
340,254
-6,973
| -2% | -$378K | 0.03% | 262 |
|
|
2025
Q4 | $17M | Sell |
347,227
-28,106
| -7% | -$1.31M | 0.03% | 318 |
|
|
2025
Q3 | $16.2M | Buy |
375,333
+20,599
| +6% | +$805K | 0.03% | 307 |
|
|
2025
Q2 | $13.6M | Buy |
354,734
+8,437
| +2% | +$322K | 0.03% | 320 |
|
|
2025
Q1 | $13.4M | Buy |
346,297
+1,778
| +0.5% | +$65.1K | 0.03% | 293 |
|
|
2024
Q4 | $11.7M | Buy |
344,519
+27,434
| +9% | +$988K | 0.03% | 313 |
|
|
2024
Q3 | $13M | Sell |
317,085
-70,091
| -18% | -$2.87M | 0.03% | 292 |
|
|
2024
Q2 | $14.9M | Sell |
387,176
-3,768
| -1% | -$159K | 0.04% | 244 |
|
|
2024
Q1 | $16.8M | Buy |
390,944
+71,285
| +22% | +$2.94M | 0.04% | 222 |
|
|
2023
Q4 | $11.8M | Buy |
319,659
+16,652
| +5% | +$598K | 0.03% | 243 |
|
|
2023
Q3 | $11M | Buy |
303,007
+5,712
| +2% | +$203K | 0.04% | 225 |
|
|
2023
Q2 | $10.6M | Buy |
297,295
+5,669
| +2% | +$203K | 0.04% | 240 |
|
|
2023
Q1 | $10.4M | Buy |
291,626
+19,829
| +7% | +$694K | 0.04% | 245 |
|
|
2022
Q4 | $9.55M | Sell |
271,797
-748
| -0.3% | -$24.9K | 0.04% | 267 |
|
|
2022
Q3 | $8.02M | Sell |
272,545
-40,945
| -13% | -$1.55M | 0.03% | 265 |
|
|
2022
Q2 | $21.3M | Buy |
313,490
+181
| +0.1% | +$9.99K | 0.08% | 150 |
|
|
2022
Q1 | $17.1M | Sell |
313,309
-2,164
| -0.7% | -$118K | 0.06% | 177 |
|
|
2021
Q4 | $17.4M | Sell |
315,473
-15,937
| -5% | -$829K | 0.06% | 191 |
|
|
2021
Q3 | $15.8M | Sell |
331,410
-9,196
| -3% | -$462K | 0.06% | 186 |
|
|
2021
Q2 | $17M | Buy |
340,606
+1,009
| +0.3% | +$48.5K | 0.05% | 193 |
|
|
2021
Q1 | $15.2M | Buy |
339,597
+18,335
| +6% | +$832K | 0.05% | 202 |
|
|
2020
Q4 | $14.8M | Sell |
321,262
-4,468
| -1% | -$205K | 0.05% | 194 |
|
|
2020
Q3 | $15.3M | Sell |
325,730
-58,251
| -15% | -$2.92M | 0.07% | 160 |
|
|
2020
Q2 | $19.6M | Sell |
383,981
-22,323
| -5% | -$1.15M | 0.09% | 131 |
|
|
2020
Q1 | $19.2M | Buy |
406,304
+35,767
| +10% | +$1.91M | 0.1% | 126 |
|
|
2019
Q4 | $21.8M | Sell |
370,537
-12,362
| -3% | -$688K | 0.09% | 131 |
|
|
2019
Q3 | $20.4M | Buy |
382,899
+73,725
| +24% | +$3.79M | 0.1% | 119 |
|
|
2019
Q2 | $15.5M | Sell |
309,174
-4,642
| -1% | -$233K | 0.07% | 142 |
|
|
2019
Q1 | $16.4M | Sell |
313,816
-10,168
| -3% | -$508K | 0.08% | 152 |
|
|
2018
Q4 | $15.5M | Sell |
323,984
-47,926
| -13% | -$2.36M | 0.08% | 149 |
|
|
2018
Q3 | $18.7M | Sell |
371,910
-13,068
| -3% | -$664K | 0.08% | 137 |
|
|
2018
Q2 | $19.4M | Sell |
384,978
-1,045
| -0.3% | -$52.6K | 0.09% | 126 |
|
|
2018
Q1 | $18.9M | Buy |
386,023
+257,488
| +200% | +$12M | 0.08% | 129 |
|
|
2017
Q4 | $5.7M | Buy |
128,535
+3,593
| +3% | +$166K | 0.03% | 190 |
|
|
2017
Q3 | $6.34M | Sell |
124,942
-248,060
| -67% | -$12.6M | 0.03% | 179 |
|
|
2017
Q2 | $20.1M | Buy |
373,002
+23,508
| +7% | +$1.25M | 0.09% | 121 |
|
|
2017
Q1 | $18.4M | Sell |
349,494
-709
| -0.2% | -$36K | 0.06% | 129 |
|
|
2016
Q4 | $16.9M | Buy |
350,203
+1,731
| +0.5% | +$85.5K | 0.06% | 107 |
|
|
2016
Q3 | $18.8M | Buy |
348,472
+842
| +0.2% | +$46.2K | 0.08% | 84 |
|
|
2016
Q2 | $18.8M | Buy |
347,630
+81,968
| +31% | +$4.32M | 0.08% | 69 |
|
|
2016
Q1 | $13.5M | Buy |
265,662
+3,755
| +1% | +$187K | 0.06% | 77 |
|
|
2015
Q4 | $13.2M | Buy |
261,907
+49,033
| +23% | +$2.5M | 0.07% | 80 |
|
|
2015
Q3 | $10.2M | Buy |
212,874
+18,886
| +10% | +$983K | 0.05% | 85 |
|
|
2015
Q2 | $10.1M | Sell |
193,988
-8,600
| -4% | -$484K | 0.04% | 91 |
|
|
2015
Q1 | $11.7M | Buy |
202,588
+14,245
| +8% | +$817K | 0.05% | 80 |
|
|
2014
Q4 | $10.1M | Sell |
188,343
-4,902
| -3% | -$274K | 0.04% | 83 |
|
|
2014
Q3 | $11.1M | Buy |
193,245
+77,048
| +66% | +$4.72M | 0.04% | 78 |
|
|
2014
Q2 | $7.77M | Buy |
116,197
+33,921
| +41% | +$2.3M | 0.03% | 101 |
|
|
2014
Q1 | $5.5M | Buy |
82,276
+8,559
| +12% | +$579K | 0.02% | 128 |
|
|
2013
Q4 | $4.92M | Buy |
73,717
+115
| +0.2% | +$7.46K | 0.02% | 132 |
|
|
2013
Q3 | $4.62M | Buy |
73,602
+2,189
| +3% | +$141K | 0.02% | 113 |
|
|
2013
Q2 | $4.46M | Buy |
+71,413
| New | +$4.53M | 0.02% | 108 |
|
Other funds holding GSK
JEST
